Patents by Inventor Chang-Zheng Chen

Chang-Zheng Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110020816
    Abstract: By modifying nucleotides from either or both the stem and loop of precursor-miRNA, greater specificity is achieved as to the mRNAs targeted. The improved efficiency in target regulation can be either mediated by direct base-pairings between targets and precursor miRNAs or indirectly by energy constraints on the availability of such base-pairings. It is found that pri- and pre-miRNA are active in the absence of functional mature miRNA, so pri- or pre-miRNA or truncated portion thereof, but not as mature miRNA, can be used as RNAi agents by themselves. Furthermore, besides the seed sequence of the stem of the pre-miRNA and 3?-extensions thereof to provide greater complementarity to the target mRNA, nucleotides in the loop can affect the activity and specificity of the precursor-miRNA and the processing and binding to target mRNA.
    Type: Application
    Filed: May 28, 2010
    Publication date: January 27, 2011
    Inventors: Chang-Zheng Chen, Robin Trujillo, Sibiao Yue
  • Patent number: 7803784
    Abstract: MicroRNAs (miRNAs) are a diverse and abundant class of ˜22-nucleotide (nt) endogenous regulatory RNAs that play a variety of roles in animal cells by controlling gene expression at the posttranscriptional level. Increased miR-181a expression in mature T cells is shown to cause a marked increase in T cell activation and augments T cell sensitivity to peptide antigens. Moreover, T cell blasts with higher miR-181a expression become reactive to antagonists. The effects of miR-181a on antigen discrimination are in part achieved by dampening the expression of multiple negative regulators in the T cell receptor (TCR) signaling pathway, including PTPN22 and the dual specificity phosphatases DUSP5 and DUSP6. This results in a reduction in the TCR signaling threshold, thus quantitatively and qualitatively enhancing T cell sensitivity to antigens.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: September 28, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Qi-Jing Li, Chang-Zheng Chen, Mark M. Davis, Jacqueline Chau
  • Publication number: 20100048674
    Abstract: The ability of miR-181a to support active signaling between Notch and pre-TCR pathways by coordinately dampening negative regulators of these pathways allows the use of miR-181a as a therapeutic target for T-ALL.
    Type: Application
    Filed: June 8, 2009
    Publication date: February 25, 2010
    Inventors: Chang-Zheng Chen, Tin Mao
  • Publication number: 20090004668
    Abstract: By employing essential nucleotides from both the stem and loop of precursor-miRNA, greater specificity is achieved as to the mRNAs that are repressed. It is found that besides the seed sequence of the stem of the pre-miRNA, nucleotides in the loop affect the activity and specificity of the cursor- and the processing and binding to target mRNA. By using both sequences in the natural pre-miRNA or modified mimetics, one can screen for cellular miRNA expression, modulate cell properties with greater specificity and investigate cellular activity as to phenotype and response to external stimuli in the presence and absence of target protein expression.
    Type: Application
    Filed: June 20, 2008
    Publication date: January 1, 2009
    Inventors: Chang-Zheng Chen, Hyeyoung Min, Gwen Liu
  • Publication number: 20080200416
    Abstract: MicroRNAs (miRNAs) are a diverse and abundant class of ˜22-nucleotide (nt) endogenous regulatory RNAs that play a variety of roles in animal cells by controlling gene expression at the posttranscriptional level. Increased miR-181a expression in mature T cells is shown to cause a marked increase in T cell activation and augments T cell sensitivity to peptide antigens. Moreover, T cell blasts with higher miR-181a expression become reactive to antagonists. The effects of miR-181a on antigen discrimination are in part achieved by dampening the expression of multiple negative regulators in the T cell receptor (TCR) signaling pathway, including PTPN22 and the dual specificity phosphatases DUSP5 and DUSP6. This results in a reduction in the TCR signaling threshold, thus quantitatively and qualitatively enhancing T cell sensitivity to antigens.
    Type: Application
    Filed: October 24, 2007
    Publication date: August 21, 2008
    Inventors: Qi-Jing Li, Chang-Zheng Chen, Mark M. Davis, Jacqueline Chau
  • Publication number: 20050075492
    Abstract: The invention relates to microRNAs, methods of producing microRNAs and methods for using microRNAs.
    Type: Application
    Filed: August 6, 2004
    Publication date: April 7, 2005
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Chang-Zheng Chen, David Bartel, Harvey Lodish
  • Publication number: 20020168660
    Abstract: Methods of marking pluripotent cells, such as stem cells, particularly hematopoietic stem cells; methods of detecting/identifying, enriching, selecting and monitoring pluripotent cells (stem cells); DNA constructs useful in the methods, stem cells, such as hematopoietic stem cells, identified by the method, as well as lineage-specific cells identified by the method; and uses for the cells are subjects of this invention.
    Type: Application
    Filed: February 15, 2002
    Publication date: November 14, 2002
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Chang-Zheng Chen, Harvey F. Lodish